Calculating AUC (linear and log-linear) BlogKnowledge Base Calculating AUC (linear and log-linear) AUC calculations are simple but nuanced. In this blog, we look at how to calculate…Ana HenryApril 2, 2025
Accumulation: What it means and how to calculate it BlogKnowledge Base Accumulation: What it means and how to calculate it In this blog, we look closely at drug accumulation ratio, to help you understand and…Ana HenryApril 2, 2025
Enhanced Absorption and Safety of MuscleBlaze CreAMP™: A Comparative Analysis With Regular Micronized Creatine Monohydrate in Healthy Male Adults Publication Enhanced Absorption and Safety of MuscleBlaze CreAMP™: A Comparative Analysis With Regular Micronized Creatine Monohydrate in Healthy Male Adults Learn how CreAMP shows higher bioavailability, longer half‑life, and lower clearance than standard creatine, analysed…CertaraApril 1, 2025
The effect of high-fat diet on the pharmacokinetics of ondansetron hydrochloride tablets in healthy Chinese subjects Publication The effect of high-fat diet on the pharmacokinetics of ondansetron hydrochloride tablets in healthy Chinese subjects Find out how high‑fat meals significantly reduce ondansetron exposure, falling outside bioequivalence bounds, analysed using…CertaraMarch 21, 2025
Effect of Food on the Pharmacokinetic Characteristics of a Single Oral Dose of D-1553, a Selective Inhibitor of KRASG12C, in Healthy Chinese Subjects` Publication Effect of Food on the Pharmacokinetic Characteristics of a Single Oral Dose of D-1553, a Selective Inhibitor of KRASG12C, in Healthy Chinese Subjects` Explore how high‑fat meals cause only modest PK changes in D‑1553, supporting administration without regard…CertaraMarch 18, 2025
Analysis of factors influencing the relationship between voriconazole plasma concentrations and adverse effects in a paediatric population Publication Analysis of factors influencing the relationship between voriconazole plasma concentrations and adverse effects in a paediatric population Discover how higher voriconazole concentrations and CYP2C19 variants predict thrombocytopenia and cholestasis in children, modelled…CertaraFebruary 25, 2025
Multidose Dalbavancin Population Pharmacokinetic Analysis for Prolonged Target Attainment in Patients Requiring Long-Term Treatment Publication Multidose Dalbavancin Population Pharmacokinetic Analysis for Prolonged Target Attainment in Patients Requiring Long-Term Treatment See how weight‑based multidose dalbavancin regimens achieve prolonged target attainment, supported by PK‑PD modelling in…CertaraFebruary 13, 2025
Certara’s Phoenix Platform – The world’s most trusted platform for PK/PD analysis and modeling Video Certara’s Phoenix Platform – The world’s most trusted platform for PK/PD analysis and modeling Today’s drug candidates are more complex than ever. But with development decisions on the line,…CertaraFebruary 12, 2025
Population pharmacokinetics of levetiracetam in Chinese adult epilepsy patients with varying renal function Publication Population pharmacokinetics of levetiracetam in Chinese adult epilepsy patients with varying renal function Learn how creatinine clearance drives levetiracetam clearance; PopPK modelling supports renal‑adjusted dosing using Phoenix NLME.CertaraFebruary 10, 2025
Bioequivalence of Water-Soluble Progesterone Injection (GenSci070) in Healthy Chinese Postmenopausal Women Volunteers Publication Bioequivalence of Water-Soluble Progesterone Injection (GenSci070) in Healthy Chinese Postmenopausal Women Volunteers Find out how GenSci070 shows bioequivalence and comparable safety to reference progesterone injection in a…CertaraJanuary 30, 2025